Morning Stock Movers: Microsoft, Regeneron, Las Vegas Sands

The video discusses the pre-market situation, highlighting Microsoft's share increase due to a buyback and dividend rise. Regeneron gains from a Department of Defense contract. CureVac faces challenges with its COVID-19 vaccine development. Citrix Systems sees interest from Elliott Management, and casino stocks are affected by regulatory issues in Macau.

What is the reason behind Microsoft's share price increase?

• A merger with another company

• A $60 billion buyback and dividend increase

• A decrease in competition

• A new product launch

Why is Regeneron seeing a rise in its stock price?

• A new partnership with a tech company

• A reduction in production costs

• A contract extension with the Department of Defense

• A breakthrough in cancer treatment

What major challenge is CureVac facing in the COVID-19 vaccine race?

• Regulatory approval in Asia

• Excessive competition

• Ending contracts with manufacturers

• Lack of funding

What recent development is happening with Citrix Systems?

• Talks about a potential sale

• A new product launch

• A merger with a competitor

• A significant drop in stock price

What is causing the decline in casino stocks like Las Vegas Sands?

• A rise in online gambling

• Regulatory issues in Macau

• A new competitor entering the market

• A decrease in tourism